General Information
Drug ID
DR00300
Drug Name
Fostamatinib
Synonyms
901119-35-5; Fostamatinib [USAN:INN]; R 788; R-788; R-788 Free acid; R-935788 Free acid; R788; R7935788; SQ8A3S5101; Tavalisse; UNII-SQ8A3S5101
Drug Type
Small molecular drug
Indication Rheumatoid arthritis [ICD11:FA20] Approved [1]
Structure
3D MOL 2D MOL
Formula
C23H26FN6O9P
Canonical SMILES
CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C
InChI
InChI=1S/C23H26FN6O9P/c1-23(2)21(31)30(11-38-40(32,33)34)20-14(39-23)6-7-17(28-20)27-19-13(24)10-25-22(29-19)26-12-8-15(35-3)18(37-5)16(9-12)36-4/h6-10H,11H2,1-5H3,(H2,32,33,34)(H2,25,26,27,28,29)
InChIKey
GKDRMWXFWHEQQT-UHFFFAOYSA-N
CAS Number
CAS 901119-35-5
Pharmaceutical Properties Molecular Weight 580.5 Topological Polar Surface Area 187
Heavy Atom Count 40 Rotatable Bond Count 10
Hydrogen Bond Donor Count 4 Hydrogen Bond Acceptor Count 15
XLogP
1.6
PubChem CID
11671467
PubChem SID
124360793 ,125164706 ,125299332 ,126665637 ,134338877 ,135262180 ,135693729 ,136367938 ,137245316 ,141853032 ,144115995 ,152159558 ,152344305 ,160681714 ,162038039 ,164043535 ,164160256 ,16775273 ,170501470 ,172087031 ,172818901 ,174006453 ,174531355 ,185997057 ,188941735 ,198973453 ,206261469 ,210274820 ,210280453 ,223366127 ,223388366 ,223684830 ,227435155 ,23769915 ,242060176 ,246229128 ,251971029 ,252215442 ,75389485 ,96026027
TTD Drug ID
D0V8HJ
DT(s) Transporting This Drug ABCB5 Transporter Info ATP-binding cassette sub-family B member 5 Substrate [2]
References
1 Fostamatinib was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. (ID: DB12010)

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.